Key facts
- Quibim’s last known valuation is $46.1M (Jul 2023).
- It has raised $71.2M; the latest was Later Stage VC ($50.0M) in Jan 2025.
- Notable investors include Plug and Play Tech Center, European Commission, Partech, UI Investissement, KFund — 31 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 31 names
- ·Watchlist + deal alerts for Quibim
- ·The full record, as it builds
Funding rounds
No funding rounds for Quibim are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Quibim
Developer of a medical imaging platform designed for quantitative analysis and biomarker extraction. The company's platform integrates deep learning algorithms and artificial intelligence with radiomics and multi-omics data processing to standardize imaging quality, automate feature extraction, and enhance disease detection, enabling healthcare providers and researchers to improve diagnostic accuracy and optimize patient monitoring through advanced imaging insights.
- Sector
- Healthcare
- HQ
- Valencia, Spain
- Founded
- 2012
- Employees
- 109
- Website
- quibim.com/
- Ownership
- Privately Held (backing)
Quibim doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Quibim shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Quibim in its N-PORT filings yet. We sweep new filings monthly.